ScinoPharm Taiwan Ltd (1789):企業の財務・戦略的SWOT分析

◆英語タイトル:ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2722
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ScinoPharm Taiwan Ltd (1789) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development (R&D) and active pharmaceutical ingredient (API) manufacturing services to the pharmaceutical industry worldwide. It provides services such as custom synthesis for early phase pharmaceutical activities to brand companies and APIs for the generic industry. The company also provides contract research and manufacturing services (CRAM) services including chemistry skill, analytical and regulatory services, chemical process development, clinical drug substances, exploratory process research and consulting services. ScinoPharm’s wholly owned subsidiaries include SPT International, Ltd., and ScinoPharm Singapore Pte Ltd. The company has research and manufacturing facilities in Taiwan and China. ScinoPharm is headquartered in Tainan, Taiwan.

ScinoPharm Taiwan Ltd Key Recent Developments

Feb 23,2018: ScinoPharm Reports Financial Performance for 2017
Feb 15,2017: ScinoPharm Reports Financial Performance for 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
ScinoPharm Taiwan Ltd – Key Facts 5
ScinoPharm Taiwan Ltd – Key Employees 6
ScinoPharm Taiwan Ltd – Key Employee Biographies 7
ScinoPharm Taiwan Ltd – Major Products and Services 8
ScinoPharm Taiwan Ltd – History 10
ScinoPharm Taiwan Ltd – Company Statement 11
ScinoPharm Taiwan Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
ScinoPharm Taiwan Ltd – Business Description 15
ScinoPharm Taiwan Ltd – Corporate Strategy 16
ScinoPharm Taiwan Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
ScinoPharm Taiwan Ltd – Strengths 17
ScinoPharm Taiwan Ltd – Weaknesses 18
ScinoPharm Taiwan Ltd – Opportunities 19
ScinoPharm Taiwan Ltd – Threats 20
ScinoPharm Taiwan Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
ScinoPharm Taiwan Ltd, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Feb 23, 2018: ScinoPharm Reports Financial Performance for 2017 32
Feb 15, 2017: ScinoPharm Reports Financial Performance for 2016 33
Section 6 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
ScinoPharm Taiwan Ltd, Key Facts 5
ScinoPharm Taiwan Ltd, Key Employees 6
ScinoPharm Taiwan Ltd, Key Employee Biographies 7
ScinoPharm Taiwan Ltd, Major Products and Services 8
ScinoPharm Taiwan Ltd, History 10
ScinoPharm Taiwan Ltd, Other Locations 13
ScinoPharm Taiwan Ltd, Subsidiaries 13
ScinoPharm Taiwan Ltd, Key Competitors 21
ScinoPharm Taiwan Ltd, Ratios based on current share price 22
ScinoPharm Taiwan Ltd, Annual Ratios 23
ScinoPharm Taiwan Ltd, Annual Ratios (Cont...1) 24
ScinoPharm Taiwan Ltd, Annual Ratios (Cont...2) 25
ScinoPharm Taiwan Ltd, Interim Ratios 27
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
ScinoPharm Taiwan Ltd, Recent Deals Summary 31
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
ScinoPharm Taiwan Ltd, Performance Chart (2013 - 2017) 26
ScinoPharm Taiwan Ltd, Ratio Charts 28
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[ScinoPharm Taiwan Ltd (1789):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tamedia AG:企業のM&A・事業提携・投資動向
    Tamedia AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tamedia AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • CareCloud Corp:医療機器:M&Aディール及び事業提携情報
    Summary CareCloud Corp (CareCloud) is a healthcare technology company that offers cloud healthcare solutions. The company offers cloud-based healthcare IT solutions. It offers revenue cycle management, electronic health records, patient engagement, practice management, and others. CareCloud provides …
  • South Broward Hospital District:企業の戦略的SWOT分析
    South Broward Hospital District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Terramin Australia Ltd:企業の戦略・SWOT・財務分析
    Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BIM Birlesik Magazalar A.S.:戦略・SWOT・企業財務分析
    BIM Birlesik Magazalar A.S. - Strategy, SWOT and Corporate Finance Report Summary BIM Birlesik Magazalar A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Talon Metals Corp.
    Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report Summary Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hill International, Inc. (HIL):企業の財務・戦略的SWOT分析
    Hill International, Inc. (HIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務分析
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Mitsui Mining & Smelting Co Ltd:企業の戦略・SWOT・財務分析
    Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Northern Biologics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Northern Biologics Inc. (Northern Biologics) is a biotech company, which develops a portfolio of antibody therapies for treating cancer. The product pipeline of the company includes MSC-1, a first-in-class antibody that acts against leukemia inhibitory factor (LIF), which is a major immunosu …
  • Amara Raja Batteries Ltd (AMARAJABAT):企業の財務・戦略的SWOT分析
    Summary Amara Raja Batteries Ltd (Amara Raja) operates as a manufacturer of lead-acid storage batteries. The company operates through two sectors automotive battery and industrial battery sectors. Its automotive battery sector offers two-wheeler batteries, four-wheeler batteries and tubular batterie …
  • BroadVision Inc (BVSN):企業の財務・戦略的SWOT分析
    Summary BroadVision Inc (BroadVision) operates as a digital technology service provider. It provides products such as vmoso. The company vmos product offers communication and collaboration, knowledge management, collaborative process management and enterprise integration. BroadVision also offers sec …
  • Statnett SF-エネルギー分野:企業M&A・提携分析
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • Piramal Glass Pvt Ltd:企業の戦略・SWOT・財務情報
    Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Maxar Technologies Ltd (MAXR):企業の財務・戦略的SWOT分析
    Maxar Technologies Ltd (MAXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mankind Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mankind Pharma Ltd (MPL) is a healthcare products provider that manufactures and markets prescriptions medicines, over-the-counter and FMCG products. The company offers tablets, infusions, capsules, injections, dry syrups and drops, among others. Its products are used in therapeutic areas of …
  • Imperial College London-医療機器分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Shire Plc (SHP)-製薬・医療分野:企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Innovotech Inc (IOT):医療機器:M&Aディール及び事業提携情報
    Summary Innovotech Inc (Innovotech) is a medical device company. The company offers services and solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Its products include InnovoSIL, the antimicrobial agents for coating onto or incorporation into medical devices; …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆